• Oric Pharmaceuticals issued inducement equity awards dated Aug. 3, 2026 to five new non-executive hires who started in July 2026.
• Awards totaled 125,400 non-qualified stock options, 20,550 restricted stock units under the 2022 Inducement Equity Incentive Plan.
• Stock options carry an exercise price set at the common stock closing price on the grant date.
• Options vest 25% after one year, then monthly over 36 months; RSUs vest in three equal annual installments.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oric Pharmaceuticals Inc published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608071630PRIMZONEFULLFEED9804976) on August 07, 2026, and is solely responsible for the information contained therein.